TrialBone marrow transplantation2022

Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning-Eudract #: 2007-002420-15.

Saskia Hell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.